TrialThe European journal of health economics : HEPAC : health economics in prevention and care2007

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.

Maureen P M H Rutten-van Mölken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.